Australia’s PBS faces heat from Trump’s new drug pricing deal

Australian Financial Review

2 December 2025 - Britain has agreed to pay 25% more for new medicines to escape Donald Trump’s pharmaceutical tariffs in a deal that will revive long running complaints by drug makers about Australian pricing and market access.

The Trump administration’s top trade official, Jamieson Greer, unveiled the deal struck between the UK and US on Monday that continues the US President’s campaign of forcing foreign nations to share more of the cost of innovation borne by American drugmakers as he simultaneously seeks to cut medicine prices at home.

Read Australian Financial Review article

Michael Wonder

Posted by:

Michael Wonder